Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D

NCT03105310 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: Pegylated interferon alfa
DRUG: Ezetimibe

Sponsor

Aga Khan University